A Dose Selection Study of Oral Calcitonin in Normal, Healthy, Postmenopausal Women.

Trial Profile

A Dose Selection Study of Oral Calcitonin in Normal, Healthy, Postmenopausal Women.

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Mar 2012

At a glance

  • Drugs Calcitonin (Primary) ; Calcitonin (Primary)
  • Indications Postmenopausal osteoporosis
  • Focus Pharmacodynamics
  • Most Recent Events

    • 08 Mar 2012 Detailed results will be published in a peer review journal and/or prestigious scientific congress, according to a Unigene Laboratories media release.
    • 30 Apr 2010 Tarsa Therapeutics added as trial sponsor and trial affiliate as reported by ClinicalTrials.gov.
    • 02 Apr 2008 Status changed from in progress to completed (source: ClinicalTrials.gov).
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top